Frontiers in Medicinal Chemistry

Volume 1

eBook: US $44 Special Offer (PDF + Printed Copy): US $345
Printed Copy: US $323
Library License: US $176
ISSN: 1567-2042 (Print)
ISSN: 1875-5763 (Online)
ISBN: 978-1-60805-672-9 (Print)
ISBN: 978-1-60805-204-2 (Online)
Year of Publication: 2004
DOI: 10.2174/97816080520421040101


Frontiers in Medicinal Chemistry is a book series devoted to the review of areas of important topical interest to medicinal chemists and others in allied disciplines. Frontiers in Medicinal Chemistry covers all the areas of medicinal chemistry, including developments in rational drug design, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, chemoinformatics, and structure-activity relationships.

Medicinal chemistry as a discipline is rapidly maturing. The study of how structure and function are related is absolutely essential to understanding the molecular basis of life. Frontiers in Medicinal Chemistry aims to contribute in a major way to the growth of scientific knowledge and insight, and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. This book series is essential for any medicinal chemist who wishes to be kept informed and up-to-date with the latest and the most important advances.

Indexed in: Scopus, EMBASE, Scilit, Chemical Abstracts, EBSCO, Ulrich's Periodicals Directory.


- Pp. i
Atta-ur-Rahman, M. Iqbal Choudhary, Allen B. Reitz, Cheryl P. Kordik
Download Free

Targeting Protein Kinases for Bone Disease: Discovery and Development of Src Inhibitors

- Pp. 3-27 (25)
Chester A. Metcalf, Marie Rose van Schravendijk, David C. Dalgarno, Tomi K. Sawyer
View Abstract

Inhibitors of Matrix Metalloproteinases: Design, Structure and Therapeutic Applications

- Pp. 29-75 (47)
Jerry W. Skiles, Nina C. Gonnella, Arco Y. Jeng
View Abstract

Mechanism-based Inhibition of Metalloproteinases

- Pp. 77-83 (7)
Dong H. Kim, Shahriar Mobashery
View Abstract

Selective COX-2 Inhibitors and Dual Acting Anti-inflammatory Drugs: Critical Remarks

- Pp. 85-95 (11)
A. Bertolini, A. Ottani, M. Sandrini
View Abstract

Protein Farnesyltransferase Inhibitors

- Pp. 97-128 (32)
Semiramis Ayral-Kaloustian, Edward J. Salaski
View Abstract

The Design of Competitive, Small-molecule Inhibitors of Coagulation Factor Xa

- Pp. 129-152 (24)
Henry W. Pauls, William R. Ewing, Yong Mi Choi-Sledeski
View Abstract

Small Molecule Activators of the Insulin Receptor: Potential New Therapeutic Agents for the Treatment of Diabetes Mellitus

- Pp. 153-164 (12)
Edgardo Laborde, Vara Prasad Manchem
View Abstract

Current Therapies and Emerging Targets for the Treatment of Diabetes

- Pp. 165-187 (23)
Allan S. Wagman, John M. Nuss
View Abstract

Designed Enediyne Antitumor Agents

- Pp. 189-214 (26)
G.B. Jones, F.S. Fouad
View Abstract

Combinatorial Approaches in Anticancer Drug Discovery: Recent Advances in Design and Synthesis

- Pp. 215-235 (21)
Sukanta Bhattacharyya
View Abstract

The Expanding Role of NMR in Rational Drug Design

- Pp. 237-271 (35)
Rickey P. Hicks, Daniel A. Nichols
View Abstract

Mass Spectrometry Based Assays for Drug Screening in the Early Phases of Drug Discovery

- Pp. 273-292 (20)
Marshall M. Siegel
View Abstract

Recent Advances in PDE4 Inhibitors as Immunoregulators and Antiinflammatory Drugs

- Pp. 293-345 (53)
Catherine Burnouf, Ingrid Devillers, Marie-Pierre Pruniaux
View Abstract

Serotonin Reuptake Inhibition: An Update on Current Research Strategies

- Pp. 347-359 (13)
D. Spinks, G. Spinks
View Abstract

Emerging β-Amyloid Therapies for the Treatment of Alzheimer's Disease

- Pp. 361-384 (24)
Kelly A. Conway, Ellen W. Baxter, Kevin M. Felsenstein, Allen B. Reitz
View Abstract

Oxidative Stress in Animal Models of Accelerated Aging, Alzheimer’s Disease and Huntington’s Disease

- Pp. 385-397 (13)
D. Allan Butterfield
View Abstract

Constitutive Activity of Brain Serotonin Receptors: Inverse Agonist Activity of Antipsychotic Drugs

- Pp. 399-408 (10)
Anil Purohit, Katharine Herrick-Davis, Milt Teitler
View Abstract

Physicochemical Profiling (Solubility, Permeability and Charge State)

- Pp. 409-475 (67)
Alex Avdeef
View Abstract

Non-peptide Opioid Receptor Ligands - Recent Advances. Part I - Agonists

- Pp. 477-500 (24)
Agnieszka Kaczor, Dariusz Matosiuk
View Abstract

Nitric Oxide Therapies in Vascular Diseases

- Pp. 501-512 (12)
E.M. Kurowska
View Abstract

Strategies to Improve Stability and Bioavailability of Peptide Drugs

- Pp. 513-528 (16)
Céline Adessi, Claudio Soto
View Abstract

The Role of Genomics in the Discovery of Novel Antibacterial Targets

- Pp. 529-542 (14)
Jerry M. Buysse
View Abstract

New Anti-HIV Agents in Preclinical or Clinical Development

- Pp. 543-579 (37)
Erik De Clercq
View Abstract

DNA Minor Groove Alkylators

- Pp. 581-594 (14)
William A. Denny
View Abstract

Applications of Small Molecule Crystallography and the Cambridge Structural Database in Drug Design

- Pp. 595-606 (12)
Johan Wouters, Frédéric Ooms
View Abstract

Compound Optimization in Early and Late Phase Drug Discovery: Acceptable Pharmacokinetic Properties Utilizing Combined Physicochemical, In Vitro and In Vivo Screens

- Pp. 607-618 (12)
Gary W. Caldwell
View Abstract

DNA-binding of Drugs Used in Medicinal Therapies

- Pp. 619-645 (27)
G. Bischoff, S. Hoffmann, R. Zhdanov
View Abstract

The Contribution of Combinatorial Chemistry to Lead Generation: An Interim Analysis

- Pp. 647-662 (16)
Anton E.P. Adang, Pedro H.H. Hermkens
View Abstract

New Paradigms in Drug Design and Discovery

- Pp. 663-681 (19)
Joseph J. Barchi, Nouri Neamati
View Abstract

Author Index

- Pp. 683
Atta-ur-Rahman, Allen B. Reitz
Download Free

Subject Index

- Pp. 685-688 (4)
Atta-ur-Rahman, Allen B. Reitz
Download Free


.Botanicals and Natural Bioactives: Prevention and Treatment of Diseases.
.Frontiers In Medicinal Chemistry.
.Alkaloids and Other Nitrogen-Containing Derivatives.
.Potential Health Benefits of Biologically Active Peptides Derived from Underutilized Grains: Recent Advances in their Isolation, Identification, Bioactivity and Molecular Analysis.